Literature DB >> 17700539

Nuclear insulin receptor substrate-1 activates promoters of cell cycle progression genes.

A Wu1, J Chen, R Baserga.   

Abstract

The insulin receptor substrate-1 (IRS-1) is a docking protein of the insulin-like growth factor-1 (IGF-1) receptor and of the insulin receptor. IRS-1 sends a strong mitogenic, anti-apoptotic signal and plays an important role in cell transformation and cancer. IRS-1 translocates to nuclei of cells, where it increases the activity of the rDNA, c-myc and cyclin D1 promoters. We show, by chromatin immunoprecipitation, occupancy by IRS-1 of the same promoters. Both promoter activation and promoter occupancy are IGF-1-dependent. In cells that respond to IGF-1 but in which IRS-1 does not translocate to nuclei, promoter occupancy is absent and promoter activation is absent or much reduced. Transcriptional activation of c-myc and cyclin D1 promoters by nuclear IRS-1 does not occur with a mutant, inactive IRS-1 protein (deletion of the phosphotyrosine-binding domain, PTB) and does not require PI3-kinase activity. Taken together, these results indicate a novel mechanism by which nuclear IRS-1 activates cell cycle genes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17700539     DOI: 10.1038/sj.onc.1210636

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  36 in total

1.  Nuclear IGF1R is a transcriptional co-activator of LEF1/TCF.

Authors:  Dudi Warsito; Sylvia Sjöström; Sandra Andersson; Olle Larsson; Bita Sehat
Journal:  EMBO Rep       Date:  2012-03-01       Impact factor: 8.807

2.  Overexpression of insulin receptor substrate-4 is correlated with clinical staging in colorectal cancer patients.

Authors:  Patricia Sanmartín-Salinas; M Val Toledo-Lobo; Fernando Noguerales-Fraguas; María-Encarnación Fernández-Contreras; Luis G Guijarro
Journal:  J Mol Histol       Date:  2017-11-28       Impact factor: 2.611

3.  Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.

Authors:  Jingjing Huang; Tingting Weng; Junsuk Ko; Ning-Yuan Chen; Yu Xiang; Kelly Volcik; Leng Han; Michael R Blackburn; Xiang Lu
Journal:  Biochem Biophys Res Commun       Date:  2018-06-23       Impact factor: 3.575

Review 4.  Hyperinsulinaemia in cancer.

Authors:  Emily J Gallagher; Derek LeRoith
Journal:  Nat Rev Cancer       Date:  2020-09-09       Impact factor: 60.716

5.  Proteomic analysis of potential keratan sulfate, chondroitin sulfate A, and hyaluronic acid molecular interactions.

Authors:  Abigail H Conrad; Yuntao Zhang; Elena S Tasheva; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-07       Impact factor: 4.799

6.  YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation.

Authors:  Africa Fernandez-L; Paul A Northcott; James Dalton; Charles Fraga; David Ellison; Stephane Angers; Michael D Taylor; Anna Marie Kenney
Journal:  Genes Dev       Date:  2009-12-01       Impact factor: 11.361

7.  IRS1 regulation by Wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype.

Authors:  Guido T Bommer; Ying Feng; Ayaka Iura; Thomas J Giordano; Rork Kuick; Hüseyin Kadikoy; Deanna Sikorski; Rong Wu; Kathleen R Cho; Eric R Fearon
Journal:  J Biol Chem       Date:  2009-10-20       Impact factor: 5.157

8.  Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer.

Authors:  Ilenia Migliaccio; Meng-Fen Wu; Carolina Gutierrez; Luca Malorni; Syed K Mohsin; D Craig Allred; Susan G Hilsenbeck; C Kent Osborne; Heidi Weiss; Adrian V Lee
Journal:  Breast Cancer Res Treat       Date:  2009-11-19       Impact factor: 4.872

9.  Insulin receptor substrate-1 deficiency promotes apoptosis in the putative intestinal crypt stem cell region, limits Apcmin/+ tumors, and regulates Sox9.

Authors:  Nicole M Ramocki; Heather R Wilkins; Scott T Magness; James G Simmons; Brooks P Scull; Ginny H Lee; Kirk K McNaughton; P Kay Lund
Journal:  Endocrinology       Date:  2007-10-04       Impact factor: 4.736

10.  Expression and function of the insulin receptor substrate proteins in cancer.

Authors:  Katerina Mardilovich; Shannon L Pankratz; Leslie M Shaw
Journal:  Cell Commun Signal       Date:  2009-06-17       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.